L'Allier PL - Search Results

1

Clinical Profiles Related to Timing of Death, Including In-Hospital Deaths Before Admission, in Patients With ST-Elevation Myocardial Infarction.

Bogaty P, L'Allier PL, Segal E, Rinfret S, Racine N, Harvey R, Ross D, Maire S, Kouz S, Carroll C, Boothroyd LJ, Kezouh A, Azzi L, Brown KA, Nasmith J, Lambert LJ. Bogaty P, et al. Am J Cardiol. 2016 Feb 1;117(3):347-52. doi: 10.1016/j.amjcard.2015.10.053. Epub 2015 Nov 18. Am J Cardiol. 2016. PMID: 26721650

2

Predictors and prognosis of suboptimal coronary blood flow after primary coronary angioplasty in patients with acute myocardial infarction.

Cura FA, L'Allier PL, Kapadia SR, Houghtaling PL, Dipaola LM, Ellis SG, Topol EJ, Brener SJ; GUSTO IIb and RAPPORT Investigators. Cura FA, et al. Am J Cardiol. 2001 Jul 15;88(2):124-8. doi: 10.1016/s0002-9149(01)01605-8. Am J Cardiol. 2001. PMID: 11448407 Clinical Trial.

3

Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation.

L'Allier PL, Ducharme A, Keller PF, Yu H, Guertin MC, Tardif JC. L'Allier PL, et al. J Am Coll Cardiol. 2004 Jul 7;44(1):159-64. doi: 10.1016/j.jacc.2004.03.056. J Am Coll Cardiol. 2004. PMID: 15234426 Free article.

4

Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial.

Tardif JC, Grégoire J, L'Allier PL, Ibrahim R, Lespérance J, Heinonen TM, Kouz S, Berry C, Basser R, Lavoie MA, Guertin MC, Rodés-Cabau J; Effect of rHDL on Atherosclerosis-Safety and Efficacy (ERASE) Investigators. Tardif JC, et al. JAMA. 2007 Apr 18;297(15):1675-82. doi: 10.1001/jama.297.15.jpc70004. Epub 2007 Mar 26. JAMA. 2007. PMID: 17387133 Clinical Trial.

5

Treatment with 5-lipoxygenase inhibitor VIA-2291 (Atreleuton) in patients with recent acute coronary syndrome.

Tardif JC, L'allier PL, Ibrahim R, Grégoire JC, Nozza A, Cossette M, Kouz S, Lavoie MA, Paquin J, Brotz TM, Taub R, Pressacco J. Tardif JC, et al. Circ Cardiovasc Imaging. 2010 May;3(3):298-307. doi: 10.1161/CIRCIMAGING.110.937169. Epub 2010 Feb 27. Circ Cardiovasc Imaging. 2010. PMID: 20190281 Clinical Trial.

6

Effect on bleeding, time to revascularization, and one-year clinical outcomes of the radial approach during primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.

Arzamendi D, Ly HQ, Tanguay JF, Chan MY, Chevallereau P, Gallo R, Ibrahim R, L'Allier P, Levesque S, Gosselin G, Deguise P, Joyal M, Gregoire J, Bonan R, Crepeau J, Doucet S. Arzamendi D, et al. Am J Cardiol. 2010 Jul 15;106(2):148-54. doi: 10.1016/j.amjcard.2010.02.028. Am J Cardiol. 2010. PMID: 20598995

7

Differential 1-year clinical outcomes for ST-segment elevation myocardial infarction related to stent thrombosis or saphenous vein graft thrombosis.

Arzamendi D, Ly HQ, Tanguay JF, Armero S, Jilaihawi H, Gallo R, Ibrahim R, L'Allier P, Blondeau L, Gosselin G, Gregoire J, Doucet S. Arzamendi D, et al. Catheter Cardiovasc Interv. 2013 Aug 1;82(2):193-200. doi: 10.1002/ccd.23300. Epub 2013 May 7. Catheter Cardiovasc Interv. 2013. PMID: 21805615

8

Hemodynamic and clinical benefits associated with chronic sildenafil therapy in advanced heart failure: experience of the Montréal Heart Institute.

Potter BJ, White M, Carrier M, Pellerin M, L'Allier PL, Pelletier GB, Racine N, Ducharme A. Potter BJ, et al. Can J Cardiol. 2012 Jan-Feb;28(1):69-73. doi: 10.1016/j.cjca.2011.09.018. Epub 2011 Nov 29. Can J Cardiol. 2012. PMID: 22129489

9

Effects of the P-selectin antagonist inclacumab on myocardial damage after percutaneous coronary intervention for non-ST-segment elevation myocardial infarction: results of the SELECT-ACS trial.

Tardif JC, Tanguay JF, Wright SR, Duchatelle V, Petroni T, Grégoire JC, Ibrahim R, Heinonen TM, Robb S, Bertrand OF, Cournoyer D, Johnson D, Mann J, Guertin MC, L'Allier PL. Tardif JC, et al. J Am Coll Cardiol. 2013 May 21;61(20):2048-55. doi: 10.1016/j.jacc.2013.03.003. Epub 2013 Mar 10. J Am Coll Cardiol. 2013. PMID: 23500230 Free article. Clinical Trial.

10

Effect of radial-to-femoral access crossover on adverse outcomes in primary percutaneous coronary intervention.

Azzalini L, Khan R, Al-Hawwas M, Hatem R, Fortier A, L'Allier PL, Ly HQ. Azzalini L, et al. Am J Cardiol. 2014 Oct 15;114(8):1165-73. doi: 10.1016/j.amjcard.2014.07.033. Epub 2014 Jul 29. Am J Cardiol. 2014. PMID: 25260813 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

108 results

Search Page